In this issue:
CD56-antibody/auristatin E-conjugate for Merkel cell carcinoma
Hidradenitis suppurativa treated with adalimumab
Real-world effectiveness of guselkumab for psoriasis
Biologics and oral small molecules for atopic dermatitis
Ustekinumab for atopic dermatitis
Short-term efficacy of biologic therapies in moderate-to-severe plaque psoriasis
Impact of trial-and-error on psoriasis biologic treatment
Structural damage progression in psoriatic arthritis with secukinumab
Long-term safety of risankizumab in moderate-to-severe plaque psoriasis
Bimekizumab for moderate-to-severe plaque psoriasis
Please login below to download this issue (PDF)